Managing the coming tsunami of genomic and cellular therapy costs
U.S. Food and Drug Administration Commissioner Scott Gottlieb was the keynote speaker at Penn’s “Cost of a Cure" conference on precision medicine, where he announced two new draft guidelines for clinical trial protocols.
FULL STORY AT Leonard Davis Institute →